Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes
Clinical trial NCT03556098 · COMPLETED
Trial details
- NCT number
- NCT03556098
- Sponsor
- Steno Diabetes Center Copenhagen
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-22
- Primary completion
- 2020-02-11
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.